abstract |
The present invention relates to novel acyclic compounds for the regulation of G protein-coupled receptors, wherein the novel compounds of the present invention relate to the regulation of G protein-coupled receptors, in particular GPR119 G protein-coupled receptors. It provides the effect of treating or preventing related diseases. |